David Lebwohl - Net Worth and Insider Trading
David Lebwohl Net Worth
The estimated net worth of David Lebwohl is at least $905,294 dollars as of 2024-11-13. David Lebwohl is the EVP, Chief Medical Officer of Intellia Therapeutics Inc and owns about 54,372 shares of Intellia Therapeutics Inc (NTLA) stock worth over $905,294. Details can be seen in David Lebwohl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Lebwohl has not made any transactions after 2024-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Lebwohl
David Lebwohl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Lebwohl owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of David Lebwohl’s form 4 insider trades.
Insider Ownership Summary of David Lebwohl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | EVP & Chief Medical Officer |
David Lebwohl Latest Holdings Summary
David Lebwohl currently owns a total of 1 stock. David Lebwohl owns 54,372 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $905,294.
Latest Holdings of David Lebwohl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | 54,372 | 16.65 | 905,294 |
Holding Weightings of David Lebwohl
David Lebwohl Form 4 Trading Tracker
According to the SEC Form 4 filings, David Lebwohl has made a total of 8 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 5,843 shares on January 3, 2024, which brought David Lebwohl around $172,135.
Insider Trading History of David Lebwohl
- 1
David Lebwohl Trading Performance
David Lebwohl Ownership Network
Ownership Network List of David Lebwohl
Ownership Network Relation of David Lebwohl
David Lebwohl Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
David Lebwohl is the EVP & Chief Medical Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, David Lebwohl made 1 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 5,843. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
David Lebwohl Mailing Address
Above is the net worth, insider trading, and ownership report for David Lebwohl. You might contact David Lebwohl via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
